In Tunisian Arab Berbers, LRRK2 p.Gly2019Ser accounts for ~30–40%5–7 of the PD cases, followed by Israeli Ashkenazi Jews at ~18% of all PD cases8–10. Here, LRRK2 is linked to Parkinson disease.